NCT06081205

Brief Summary

This is a registry of the patients that are admitted to CICU and treated by the Scientific Staff of the 2nd Department of Cardiology, due to an acute cardiovascular disease (acute coronary syndrome, acute heart failure, arrhythmia, pulmonary embolism, cardiac tamponade etc) in order to investigate the clinical characteristics of the patients, their outcome, identify the factors that could predict the in-hospital mortality and compare the results with the predicted by established risk scores. Furthermore, the study will investigate the one-year mortality and also the major adverse cardiac events (MACE - acute myocardial infarction, stroke, or cardiovascular death) will be measured.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
12mo left

Started Apr 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Apr 2023Apr 2027

Study Start

First participant enrolled

April 27, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 10, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 13, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 26, 2027

Expected
Last Updated

October 13, 2023

Status Verified

October 1, 2023

Enrollment Period

3 years

First QC Date

July 10, 2023

Last Update Submit

October 6, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • In-hospital mortality

    In-hospital all-cause mortality of patients with acute cardiovascular disease that require treatment in a CICU

    During the index admission (up to 8 weeks)

  • 30-day mortality

    30-day all-cause mortality of patients with acute cardiovascular disease that require treatment in a CICU

    30 days after discharge from hospital

  • 1-year mortality

    1-year all-cause mortality of patients with acute cardiovascular disease that require treatment in a CICU

    1-year after discharge from hospital

Secondary Outcomes (3)

  • In-hospital major adverse cardiac events (MACE)

    During the index admission (up to 8 weeks)

  • 30-day major adverse cardiac events (MACE)

    30 days after discharge from hospital

  • 1-year major adverse cardiac events (MACE)

    1-year after discharge from hospital

Interventions

all patients admitted in the CICU will be enrolled in the study provided they give their informed consent.

Also known as: no further interventions

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients that are admitted through the Emergency Department of the UHI, transferred by other hospital clinics or by other regional secondary hospitals, with an acute cardiovascular disease that requires treatment in a CICU and are under scientific supervision of the 2nd Department of Cardiology, irrespectively of gender and age. In order to be enrolled, patients or their relative/legal representative (in cases stated above) must have signed an informed consent form

You may qualify if:

  • All patients admitted to the Cardiac Intensive Care Unit (CICU) through the Emergency Department of the UHI
  • All patients transferred to the CICU from other hospital departments or other regional secondary hospitals
  • Patients with an acute cardiovascular disease that requires treatment in a CICU
  • Patients who are under scientific supervision of the 2nd Department of Cardiology
  • Patients (or their relative/legal representatives) that have signed the informed consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Ioannina

Ioannina, Epirus, 45500, Greece

RECRUITING

MeSH Terms

Conditions

Shock, Cardiogenic

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisShock

Study Officials

  • Lampros K Michalis, MD, PhD

    Professor of Cardiology, Director of the 2nd Cardiology Department, University Hospital of Ioannina

    STUDY DIRECTOR

Central Study Contacts

Katerina K Naka, MD, PhD

CONTACT

Aidonis Rammos, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Cardiology

Study Record Dates

First Submitted

July 10, 2023

First Posted

October 13, 2023

Study Start

April 27, 2023

Primary Completion

April 26, 2026

Study Completion (Estimated)

April 26, 2027

Last Updated

October 13, 2023

Record last verified: 2023-10

Locations